May 9, 2008 – Philips launched the new Xcelera R2.2, the latest version of its Xcelera multimodality cardiology image management, analysis and reporting solution, offering improved support for imaging studies and data from key cardiac subspecialties including cardiac catheterization and cardiovascular ultrasound, and additionally supports nuclear cardiology, cardiac CT, cardiac MRI and electroph

May 8, 2008 – The first human procedure using the Volcano OCT imaging catheter, which uses optical coherence tomography (OCT) designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, was performed by Patrick Serruys, M.D., at the Thoraxcenter, in Rotterdam, Netherlands.

May 7, 2008 - The FDA has cleared for marketing a new safety engineered short-term peripheral intravenous (IV) catheter, the VantageCath, which is designed to reduce exposure to bloodborne pathogens during the placement of the catheter and also provide the clinician with desirable feature sets.

May 7, 2008 – Lantheus Medical Imaging initiated CaRES (Contrast Echocardiography REgistry for Safety Surveillance), a multicenter Phase IV observational study that will further evaluate the safety profile of DEFINITY Vial For (Perflutren Lipid Microsphere) Injectable Suspension in patients with suboptimal echocardiograms, to explore the safety profile of DEFINITY for which the FDA posted an alert on Oct. 10, 2007.

CorMatrix ECM by CorMatrix Cardiovascular is for Cardiac Tissue Repair, which utilizes the company’s proprietary extracellular matrix (ECM) biomaterial technologies that harness the body’s innate ability to repair damaged cardiovascular tissue.

A safety engineered short-term peripheral intravenous (IV) catheter, the VantageCath, is designed to reduce exposure to bloodborne pathogens during the placement of the catheter and also provide the clinician with desirable feature sets.

May 7, 2008 - GE Healthcare signed a nonexclusive agreement with Merck and Co. to provide spin signal technology (SST) for imaging of the lungs to help to advance respiratory treatment development, as part of GE Healthcare’s strategy to accelerate the development of new therapeutics.

GE Healthcare’s drug development strategy includes giving pharmaceutical companies access to novel molecular imaging agents to assess the impact of potential drugs in animal models and, when appropriate, human subjects.

May 6, 2008 - Donal Quinn has been appointed new head of the Diagnostics division of the Siemens Healthcare Sector, succeeding Jim Reid-Anderson, to become the new CEO of this sector.

Prior to his new job, Quinn served as executive vice president and chief customer officer of the Diagnostics division since November 2007.

May 6, 2008 - Vascular Insights received 510(k) clearance from the FDA to market its ClariVein infusion catheter for infusion of physician-specified agents in the peripheral vasculature.

ClariVein is a percutaneous, 2 2/3 Fr (0.035-inch) catheter, containing a rotating wire driven by a motor, that enhances fluid dispersion in the treatment area.

May 6, 2008 - Philips has introduced new disposable adult ECG leadwire electrodes designed to be easy to use and to provide patient monitoring products to assist in the prevention of cross-contamination.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now